Paul Edison

19PUBLICATIONS
101CO-AUTHORS
GlycoconjugatesMedical infection agents (incl. prions)Animal production not elsewhere classifiedPredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 01, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.

Paul Edison, Grazia Daniela Femminella, Craig Ritchie

|Sep 04, 2025
Association between FDG- and TSPO-PET signals across human and animal studies investigating neurodegenerative conditions: a systematic review.

Luiza S Machado, Pedro Vidor, Lavínia Perquim

|Jun 24, 2025
Utility, Costs and Cost-Utility of Amyloid-PET in the Diagnostic Process of Memory Clinic Patients: A Trial-Based Economic Evaluation From AMYPAD-DPMS.

Ingrid S van Maurik, Daniele Altomare, Lyduine E Collij

|Dec 20, 2024
Evaluating clinical meaningfulness of anti-β-amyloid therapies amidst amyloid-related imaging abnormalities concern in Alzheimer's disease.

Manal Aljuhani, Azhaar Ashraf, Paul Edison

|Dec 09, 2024
Neuroinflammation in Alzheimer disease.

Michael T Heneka, Wiesje M van der Flier, Frank Jessen

|Nov 27, 2024
Cardiovascular risk and obesity impact loss of grey matter volume earlier in males than females.

Joseph Nowell, Steve Gentleman, Paul Edison

Pageof 4

Frequent Collaborators

4 joint publications

Rainer Hinz

2 joint publications

Henrik Zetterberg

2 joint publications

Paul M Matthews

2 joint publications

Nicholas R Livingston